Cybin completes its 51st pre-clinical molecule study, with four of these molecules already being advanced to toward clinical evaluations.
Maine Lawmakers Vote to Decriminalize All Drugs
Possession of illicit drugs like heroin and cocaine could be decriminalized in Maine, following two favorable votes by lawmakers last week.
Western Illinois University Graduates First Cannabis & Culture Minor
The first of five Western Illinois University students with a minor in Cannabis & Culture was part of the school’s spring 2021 graduating class.
Gold edges higher, attempts to recover from sharpest weekly skid in over a year
Gold futures on Monday were headed modestly higher, with the precious metal attempting to claw back from its steepest weekly decline since March 2020.
Base metals demand expected to benefit from green revolution – report
A report by market researcher CRU Group forecasts that demand for zinc, copper, and nickel will continue to grow in the next two decades, particularly in China where government stimulus may drive it to levels even higher than what was predicted in pre-pandemic forecasts.
‘NJ Weedman’ Running for Governor with Write-In Campaign
Edward Forchion, the cannabis advocate known as “NJ Weedman,” is running a write-in campaign for New Jersey governor following a successful challenge of his nominating petitions by the Democratic State Committee, NJ.com reports.
Atai IPO Day An Underwhelming Event
The much-anticipated IPO for atai Life Sciences (US:ATAI) ended up being anti-climactic instead.
China's release of national copper reserves not a game-changer for price rally - analysts
Copper prices have been taking a hit, falling to a two-month low after China announced that it would sell its strategic reserves of the base metal to cool down what has been a hot market.
Why copper’s drop from all-time highs may not mark the end of its run up in prices
Copper prices have dropped from a record high last month following efforts by China to stem the rally in commodities.
MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression
MINDCURE announces two, new ketamine-based treatment protocols: one for pain and one for depression. These new protocols will be distributed via iSTRYM.
Copper price and China reserves: sell on rumor, buy on fact
Copper prices rose on Wednesday, recovering from a seven-week low struck Tuesday, despite China’s campaign to reduce speculation and cool rampant metals markets.
Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company
Novamind has just completed a strategic investment of US$1 million in a private psychedelics company, as part of a $25 million Series A financing.
